Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.

NCT06396013 is registered in ClinicalTrials.gov with Beijing Hospital of Traditional Chinese Medicine as lead sponsor.

NCT NCT06396013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06396013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.
Lead sponsor
Beijing Hospital of Traditional Chinese Medicine
Phase
Phase 1
Overall status
Unknown status
Start date
June 1, 2024
Completion date
July 31, 2026
Enrollment
96 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis